Profound Medical (TSE:PRN) Stock Price Up 2.5%

Profound Medical Corp. (TSE:PRN)’s stock price was up 2.5% during mid-day trading on Friday . The company traded as high as C$12.00 and last traded at C$11.89. Approximately 6,761 shares were traded during mid-day trading, an increase of 31% from the average daily volume of 5,154 shares. The stock had previously closed at C$11.60.

Profound Medical Stock Up 2.5 %

The company has a debt-to-equity ratio of 15.78, a current ratio of 5.41 and a quick ratio of 14.98. The stock has a market capitalization of C$290.47 million, a price-to-earnings ratio of -6.76 and a beta of 1.27. The firm’s fifty day moving average is C$11.09 and its 200-day moving average is C$11.16.

Profound Medical (TSE:PRN) last issued its earnings results on Thursday, May 9th. The company reported C($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.41) by C$0.06. The company had revenue of C$2.58 million during the quarter, compared to analyst estimates of C$3.24 million. On average, sell-side analysts predict that Profound Medical Corp. will post -1.9000001 earnings per share for the current year.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.